dipyridamole and endothelin-1

dipyridamole has been researched along with endothelin-1 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldoncini, R; Bellini, C; De Marzio, P; Desideri, G; Ferri, C; Morelli, S; Santucci, A1
Aigrain, Y; de Lagausie, P; Dinh-Xuan, AT; Forgues, D; Mercier, JC; Thébaud, B1
Humphrey, J; Mullan, M; Paris, D; Parker, T; Town, T1
Mei, Z; Xiaozhen, H; Yu, S; Yun, Z1
Affricano, C; Bondanini, F; Cassone, R; Gaspardone, A; Gaudio, C; Moroni, C; Schillaci, O; Tolone, S1

Trials

1 trial(s) available for dipyridamole and endothelin-1

ArticleYear
Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.
    Blood pressure, 2010, Volume: 19, Issue:1

    Topics: Administration, Sublingual; Adrenergic beta-Antagonists; Aged; Blood Flow Velocity; Blood Pressure; Brachial Artery; Carbazoles; Carvedilol; Coronary Circulation; Diastole; Dipyridamole; Echocardiography, Transesophageal; Endothelin-1; Endothelium, Vascular; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Injections, Intravenous; Male; Metoprolol; Middle Aged; Nitroglycerin; Propanolamines; Vasodilation; Vasodilator Agents

2010

Other Studies

4 other study(ies) available for dipyridamole and endothelin-1

ArticleYear
Plasma endothelin-1 levels during transient acute myocardial ischaemia in men: effects of coronary revascularization.
    European journal of clinical investigation, 1997, Volume: 27, Issue:6

    Topics: Adult; Angina Pectoris; Case-Control Studies; Dipyridamole; Echocardiography; Endothelin-1; Exercise Test; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization

1997
ET(A)-receptor blockade and ET(B)-receptor stimulation in experimental congenital diaphragmatic hernia.
    American journal of physiology. Lung cellular and molecular physiology, 2000, Volume: 278, Issue:5

    Topics: Acetylcholine; Animals; Antihypertensive Agents; Cyclic GMP; Dipyridamole; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Female; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Hypertension, Pulmonary; Nitric Oxide; Nitroprusside; Peptides, Cyclic; Phosphodiesterase Inhibitors; Pregnancy; Pulmonary Circulation; Purinones; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Sheep; Vasoconstrictor Agents; Vasodilator Agents; Viper Venoms

2000
beta-Amyloid vasoactivity and proinflammation in microglia can be blocked by cGMP-elevating agents.
    Annals of the New York Academy of Sciences, 2000, Volume: 903

    Topics: Amyloid beta-Peptides; Animals; Aorta; Cyclic GMP; Dipyridamole; Endothelin-1; In Vitro Techniques; Inflammation; Leukotriene B4; Microglia; Muscle, Smooth, Vascular; Nitroprusside; Peptide Fragments; Rats; Vasoconstriction

2000
Endothelin-1 in hypertensive patients with ischemic heart disease.
    Internal and emergency medicine, 2019, Volume: 14, Issue:7

    Topics: Adult; Dipyridamole; Echocardiography; Endothelin-1; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Retrospective Studies

2019